about
hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways.Tp53 and its potential therapeutic role as a target in bladder cancer.New Phage Display-Isolated Heptapeptide Recognizing the Regulatory Carboxy-Terminal Domain of Human Tumour Protein p53.Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy.Comprehensive analyses of somatic TP53 mutation in tumors with variable mutant allele frequency.Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells.Targeting the DNA Damage Response in OSCC with TP53 Mutations.
P2860
Q33913833-14416202-9ECE-4C94-B044-45DF635AB116Q38436074-AB838FB7-259E-4380-95FB-5BE4E998079BQ38657267-6CA8601E-E153-40E3-AA48-B04B8A8612AFQ39229004-F686F53F-DFBA-4A05-BD44-5922B568B131Q41613769-1DB0B3AA-2CFF-4496-A934-26C9A64A803DQ47110143-7195ECD2-4BC7-4A49-A122-52F4052A240BQ52729908-BB2D52D8-A662-4CC3-8541-E054033126D0
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting mutant p53 for cancer therapy.
@en
Targeting mutant p53 for cancer therapy.
@nl
type
label
Targeting mutant p53 for cancer therapy.
@en
Targeting mutant p53 for cancer therapy.
@nl
prefLabel
Targeting mutant p53 for cancer therapy.
@en
Targeting mutant p53 for cancer therapy.
@nl
P2093
P2860
P356
P1433
P1476
Targeting mutant p53 for cancer therapy.
@en
P2093
Moshe Oren
Varda Rotter
P2860
P304
P356
10.18632/AGING.100992
P577
2016-06-26T00:00:00Z